TABLE 6.
Susceptibility | Ertapenem |
Cefotaxime |
|||||||
---|---|---|---|---|---|---|---|---|---|
blaCphA |
blaAQU-1 |
blaMOX3 |
|||||||
No. (%) of isolates |
P value | No. (%) of isolates |
P value | No. (%) of isolates |
P value | ||||
Positive (n = 83) | Negative (n = 58) | Positive (n = 20) | Negative (n = 141) | Positive (n = 59) | Negative (n = 82) | ||||
Nonsusceptible | 4 (4.8) | 1 (1.7) | 0.65 | 2 (10) | 0 | 0.019 | 4 (6.8) | 3 (3.7) | 0.40 |
Susceptible | 79 (95.2) | 57 (98.3) | 18 (90) | 121 (85.8) | 55 (93.2) | 79 (96.3) |